In a study to evaluate drug efficacy, the manufacturer of a new
type of generic drug for treating a
disease wants to investigate the effectiveness of this generic drug
as compared to the traditional
brand name drug, At the present time, the brand name drug is the
only approved treatment for the
disease. Patients diagnosed with the disease have low concentration
of a specific factor in their
blood. Treatment with the brand name drug will result in an
increase in the concentration of the
specific factor in the blood. An experiment is conducted in which
10 patients currently with the
disease are randomly assigned to receive either the generic drug or
the brand name drug for a
period of 9 months. After 9 months have elapsed, a measure of the
concentration level of the
specific factor in the blood is obtained for each patient. The
results are shown in Table Q1.
Brand name drug | 11 | 9 | 8 | 10 | 10 |
Generic drug | 9 | 8 | 7 | 9 | 8 |
(a) At a 5 % level of significance, apply a two-sample t test to
determine whether there is
any difference in the concentration levels between brand name drug
and generic drug.
Comment on the results.
(15 marks)
(b) Construct a 90 % confidence interval for the difference in the
mean concentration
levels between brand name drug and generic drug.
(3 marks)
(c) Suppose now the manufacturer wishes to demonstrate whether the
concentration level
of brand name drug exceeds that of generic drug by more than 1,
apply a two-sample t
test to analyze the problem based on 1 % level of
significance.
(8 marks)
(d) For part (i) above, use R to perform the two-sample t test.
Show the screenshots of the
R commands and output results.
(4 marks)
Soolution-A:
Ho:
Ha:
mu1--mean of brand name drug
mu2-mean of generic drug
alpha=0.05
t=x1bar-x2bar/sqrt(s1^2/n1+s2^2/n2)
For
Brandname drug
sample mean=x1bar=9.6
sample standard deviation=s1=1.140175
sample size=n1=5
For Generic drug
sample mean=x2bar=8.2
sample standard deviation=s2=0.83666
sample size=n2=5
t=(9.6-8.2)/sqrt(1.140175^2/5+0.83666^2/5)
t= 2.213595
test statistic,t= 2.213595
df=n1+n2-2=5+5-2=8
p value in excel is
=T.DIST.2T( 2.213595,8)
=0.057756258
=0.0578
p>0.05
Do not reject Ho
Accept Ho
Conclusion:
There is no suffcient statistical evidence at 5% level of
significance to conclude that there is
any difference in the concentration levels between brand name drug
and generic drug.
(b) Construct a 90 % confidence interval for the difference in
the mean concentration
levels between brand name drug and generic drug.
Sd=ssqrt(1.2/5-1)
Sd= 0.5477226
df=n-1=5-1=4
alpha=0.10
alpha/2=0.10/2=0.05
t critical value in excel
=T.INV(0.05,4)
=2.13185
90% confidence interval for difference in means
=dbar+-tcrit*sd/sqrt(n)
=1.4+-2.13185* 0.5477226/sqrt(5)
=1.4-(2.13185* 0.5477226)/sqrt(5),1.4+(2.13185* 0.5477226)/sqrt(5)
= 0.8778055, 1.922195
90% lower limit mean difference=0.8778055
90% upper limit mean difference=1.922195
c) Suppose now the manufacturer wishes to demonstrate whether
the concentration level
of brand name drug exceeds that of generic drug by more than 1,
apply a two-sample t
test to analyze the problem based on 1 % level of significance.
Ho:
Ha:
alpha=0.01
t=((9.6-8.2)-1)/(sqrt(1.140175^2/5+0.83666^2/5))
t=0.6324557
df=n1+n2-2=8
pvalue in excel
==T.DIST.RT(0.6324557,8)
=0.272368598
p value=0.2724
p>0.01
Do not reject Ho
Accept Ho
There is no suffcient statistical evidence at 1% level of
significance to conlcude that the concentration level
of brand name drug exceeds that of generic drug by more than 1.
(d) For part (i) above, use R to perform the two-sample t test.
Show the screenshots of the
R commands and output results.
Rcode:
Brand_name_drug <- c(11, 9,
8, 10, 10)
Generic_drug <- c( 9 ,8
,7, 9, 8)
t.test(Brand_name_drug,Generic_drug)
Output:
data: Brand_name_drug and Generic_drug
t = 2.2136, df = 7.3394, p-value = 0.06072
alternative hypothesis: true difference in means is not equal to
0
95 percent confidence interval:
-0.08161171 2.88161171
sample estimates:
mean of x mean of y
9.6 8.2
t=2.2136
p=0.06072
p>0.05
Do not reject Ho
There are no differences in means of Brand name drug and generic drug
In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug...
7. A study was conducted to investigate the effectiveness of a new drug for treating Stage 4 AIDS patients. A group of AIDS patients was randomly divided into two groups. One group received the new drug; the other group received a placebo. The difference in mean subsequent survival (those with drugs - those without drugs) was found to be 1.04 years and a 95% confidence interval was found to be 1.04 ± 2.37 years. Based upon this information: Select one...
Investigators want to determine the effectiveness of a new drug in lowering cholesterol. They conduct a small clinical trial in which patients were randomized to receive the new drug or placebo. The total cholesterol was measured after ten weeks on the assigned treatment. The table below shows the results. Sample size (n) Mean Clostrol SD New drug 30 198.8 26.7 Placebo 30 215.4 30.3 Is there sufficient evidence to conclude a difference in mean cholesterol for patients on the...
1) Investigators want to determine the effectiveness of a new drug in lowering cholesterol. They conduct a small clinical trial in which patients were randomized to receive the new drug or placebo. The total cholesterol was measured after ten weeks on the assigned treatment. The table below shows the results. Sample Size (n) Mean Cholesterol SD New drug 30 198.8 26.7 Placebo 30 215.4 30.3 Is there sufficient evidence to conclude a difference in mean cholesterol for patients on the...
help with all parts please A certain drug can be used to reduce the acid produced by the body and heal damage to the esophagus due to acid reflux. The manufacturer of the drug claims that more than 94% of patients taking the drug are healed within 8 weeks. In clinical trials, 223 of 234 patients suffering from acid reflux disease were healed after 8 weeks. Test the manufacturer's claim at the a=0.01 level of significance 5% of the population...
A pharmaceutical company claims that its new drug reduces systolic blood pressure. The systolic blood pressure (in millimeters of mercury) for nine patients before taking the new drug and 2 hours after taking the drug are shown in the table below. Is there enough evidence to support the company's claim? Let d=(blood pressure before taking new drug)?(blood pressure after taking new drug) . Use a significance level of ?=0.05 for the test. Assume that the systolic blood pressure levels are...
2. The manufacturer of a drug that fights acid reflux claims that over 94% of patients who take the drug feel relief within 8 weeks. In clinical trials, 213 out of 224 patients suffering from acid reflux who took this drug felt relief after 8 weeks. Test the manufacturer's claim that at least 94% of patients felt relief at the a = 0.01 level of significance. HO: H1: P-level: Result: Conclusion:
2. Researchers are evaluating a new drug for the treatment of Type II diabetes. They ran- domly assign 20 volunteers with a history of poor glucose control levels to two groups the Treatment group gets the experimental drug on trial, while the Control group re- ceives a standard drug. At the end of the clinical trial, participants have their A1C (glycated hemoglobin, a measure of long-term blood glucose levels) tested, the results are summarized in the table below Group A1C...
Efficacy of a new drug, referred to as Drug 2 is tested over the already existing drug,referred to as Drug 1, for a particular disease. The data on the number of people usingDrug 1 and Drug 2 vs. people who are cured or not cured are given in Table 1. Test H0 that there is no difference between Drug 1 and Drug 2 in curing people, at 5% level of significance. Use table 1: cured not cured total drug 1...
Artan drug can be used to reduce the acid produced by the body and heal damage to the esophagus due to acid reflux. The manufacturer of the drug claims that more than 92% of patients taking the drug are healed within 8 weeks. In clinical trials, 214 of 231 patients suffering from acid reflux disease were heated after Test the manufacturer's claim at the a=0.1 level of significance. Because npo (-)-010, the sample size is 5% of the population size,...
(1 point) A new drug to lower total cholesterol is being tested. A study is designed to evaluate the efficacy of the drug. Sixteen patients agree to participate in the study and each is asked to take the new drug for 4 weeks. Before starting the treatment, each patient's total cholesterol level is measured. After taking the drug for 4 weeks, each patient's total cholesterol level is measured again. The 99% confidence interval for the change in total cholesterol (After...